Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study.
Reeve BWP, Ndlangalavu G, Mishra H, Palmer Z, Tshivhula H, Rockman L, Naidoo S, Mbu DL, Naidoo CC, Derendinger B, Walzl G, Malherbe ST, van Helden PD, Semitala FC, Yoon C, Gupta RK, Noursadeghi M, Warren RM, Theron G.
Reeve BWP, et al. Among authors: theron g.
Lancet Glob Health. 2024 May;12(5):e793-e803. doi: 10.1016/S2214-109X(24)00052-4. Epub 2024 Apr 4.
Lancet Glob Health. 2024.
PMID: 38583458
Free PMC article.